There are 15,358 results relating to "Medicin Viagra-m"
Order by
|
Committee reports
Date published:
21 August 2018
PE1517 - Polypropylene Mesh Medical Devices - Litigation and global concerns
Medsafe referred to this as "the strongest action possible under current legislation".viiiNew Zealand Medicines and Medical Devices Safety Authority.
Questions and Answers
Date answered:
27 May 2025
S6W-37551
Before a company can place a medicine on the market in the UK it has to obtain regulatory approval by submitting data demonstrating the quality, safety and efficacy of the medicine in terms of treating a specified condition.
Questions and Answers
Date answered:
25 February 2025
S6W-34504
In April 2023, the Chief Pharmaceutical Officer (CPO) announced an Independent Medicines Homecare Review in response to reports of failings in the standards of care provided across Scotland and the increasing demand for medicines homecare provision.The CPO will be publishing the Homecare Medicines Review before the end of March.
Questions and Answers
Date answered:
6 August 2024
S6W-28579
The Medicines and Healthcare Products Regulatory Agency (MHRA) is responsible for compliance with the regulatory requirements which govern the manufacture, distribution, retail sale/supply and advertisement of medicinal products, and the Scottish Government continues to work with and raise concerns to MHRA on these i...
Questions and Answers
Date answered:
21 September 2021
S6W-02813
To ask the Scottish Government what action it can take to improve (a) confidence in medicinal cannabinoids among clinicians prescribing treatments for chronic pain and (b) the availability and affordability of medicinal cannabis in Scotland.
Official Report
Meeting date:
13 January 2022
Meeting of the Parliament 13 January 2022
As a result of Scottish Government reforms and investment in recent years, we have significantly increased access to new medicines. Neil Gray is correct—the first generic version of sapropterin has received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency.
Last updated:
2 November 2022
PE1865_KKKK
I take these concerns very seriously and as you are aware, both informed consent and effective communication are key features in Realistic Medicine, which the Scottish Government champions.
Last updated:
7 March 2023
BB20200330
Members are advised to lodge amendments in good time before the beginning of a Stage and as early as possible during the day. (G) = Government Bill; (M) = Member’s Bill; (C) = Committee Bill; (P) = Private Bill; (H) = Hybrid Bill.
Questions and Answers
Date answered:
17 July 2025
S6W-38879
The supply of medicines and the associated legislation are a reserved matter for the UK Government and the Scottish Government continues to engage with them on all medicine supply issues.
Questions and Answers
Date answered:
11 December 2023
S6W-23194
If any cystic fibrosis medicine is not recommended in the final multiple technology appraisal (MTA) guidance, clinicians in Scotland will be able to request the use of that medicine on a case-by-case basis for individual patients using the Peer Approved Clinical System (PACS) Tier Two process.
